Drug Master Files for: DESVENLAFAXINE SUCCINATE
✉ Email this page to a colleague
DESVENLAFAXINE SUCCINATE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 25348 | I | II | 10/22/2011 | CADILA HEALTHCARE LTD | DESVENLAFAXINE BASE |
| 25447 | A | II | 2/8/2012 | CADILA HEALTHCARE LTD | DESVENLAFAXINE SUCCINATE |
| 25612 | A | II | 12/22/2011 | MEDICHEM MANUFACTURING MALTA LTD | MED-200400/M (Desvenlafaxine Succinate) |
| 25656 | A | II | 1/13/2012 | WOCKHARDT LTD | DESVENLAFAXINE SUCCINATE MONOHYDRATE |
| 25727 | A | II | 3/26/2012 | LUPIN LTD | DESVENLAFAXINE BENZOATE |
| 25747 | I | II | 1/30/2012 | TEVA PHARMACEUTICAL INDUSTRIES LTD | DESVENLAFAXINE SUCCINATE HPMC PRELIMINARY MIX |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
